View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-1453
ICR Reference No:
202410-0920-005
Status:
Historical Active
Previous ICR Reference No:
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-24FI
Title:
[NCCHPHP] Comprehensive Evaluations of theDP-23-003, DP-23-004, and DP-23-0005 Cooperative Agreement Programs: The National Cardiovascular Health Program, The Innovative Cardiovascular Health Program
Type of Information Collection:
New collection (Request for a new OMB Control Number)
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
12/16/2024
Retrieve Notice of Action (NOA)
Date Received in OIRA:
11/08/2024
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
12/31/2027
36 Months From Approved
Responses
316
0
0
Time Burden (Hours)
484
0
0
Cost Burden (Dollars)
0
0
0
Abstract:
The purpose of the project is to conduct a comprehensive implementation and outcome evaluation to assess the unique contributions of The National Cardiovascular Health Program (The National CVH Program), The Innovative Cardiovascular Health Program (The Innovative CVH Program), and Well-Integrated Screening and Evaluation of Women Across the Nation (WISEWOMAN) cooperative agreements to identify promising cardiovascular disease (CVD) prevention and management practices that can be scaled and replicated, advance health equity, and the transformation of health systems for improved CVD prevention and management. The programs work together to create efficiencies and improve outcomes in jurisdictions that receive funding for two or more of the cooperative agreements. This evaluation aims to describe program implementation, assess the extent to which short-term, intermediate, and long-term outcomes have been met, and estimate the costs involved in program implementation.
Authorizing Statute(s):
PL:
Pub.L. 117 - 328 136 STAT. 4459
Name of Law: An Act
US Code:
42 USC 247b
Name of Law: Project grants for Preventive Health Services
US Code:
42 USC Title IV, Sec. 4002, 300u-11
Name of Law: Affordable Care Ac, Prevention and Helath Fund
US Code:
42 USC Title XV, Sec. 1509
Name of Law: Public Health Service Act
US Code:
42 USC Sec. 1502, 3001
Name of Law: Public Health Service Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
89 FR 38151
05/07/2024
30-day Notice:
Federal Register Citation:
Citation Date:
89 FR 88778
11/08/2024
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
32
IC Title
Form No.
Form Name
Comprehensive Evaluation Resource Use and Cost Inventory Tool_Partner (Attachment 5b)
0920-24FI
Cost Study – Partner Interview Guide
Comprehensive Evaluation Resource Use and Cost Inventory Tool_Recipient (Attachment 5a)
0920-24FI
Comprehensive Evaluation Resource Use and Cost Inventory Tool (Recipient)
Cost Study Interview Guide_Partner (Attachment 5d)
0920-24FI
Cost Study – Partner Interview Guide
Cost Study Interview Guide_Recipient (Attachment 5c)
0920-24FI
Cost Study – Recipient Interview Guide
Eval Assessment CCL Partner Interview Guide NCHP_ICHP (Attachment 3n)
0920-24FI
Evaluability Assessment Partner Interview Guide
Eval Assessment CCL Partner Interview Guide WW (Attachment 3o)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Clinical Quality Measure – WISEWOMAN
Eval Assessment CCL Recipient Interview Guide NCHP_ICHP (Attachment 3l)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Community Clinical Links – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Eval Assessment CCL Recipient Interview Guide WW (Attachment 3m)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Community Clinical Links – WISEWOMAN
Eval Assessment CQM Partner Interview Guide NCHP_ICHP (Attachment 3f)
0920-24FI
Evaluability Assessment Partner Interview Guide
Eval Assessment CQM Partner Interview Guide WW (Attachment 3g)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Clinical Quality Measure – WISEWOMAN
Eval Assessment CQM Recipient Interview Guide NCHP_ICHP (Attachment 3d)
0920-24FI
In-Depth Assessment – Evaluability Assessment Learning Collaborative Interview Guide – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Eval Assessment CQM Recipient Interview Guide WW (Attachment 3e)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Clinical Quality Measure – WISEWOMAN
Eval Assessment LC Interview Guide_NCHP_ICHP (Attachment 3c)
0920-24FI
In-Depth Assessment – Evaluability Assessment Learning Collaborative Interview Guide – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Eval Assessment TBC Partner Interview Guide NCHP_ICHP (Attachment 3j)
0920-24FI
Evaluability Assessment Partner Interview Guide
Eval Assessment TBC Partner Interview Guide WW (Attachment 3k)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Clinical Quality Measure – WISEWOMAN
Eval Assessment TBC Recipient Interview Guide NCHP_ICHP (Attachment 3h)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Team-Based Care – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Eval Assessment TBC Recipient Interview Guide WW (Attachment 3i)
0920-24FI
In-Depth Assessment – Evaluability Assessment Recipient Interview Guide – Team-Based Care – WISEWOMAN
Evaluability Assessment Nomination Form_NCHP_ICHP (Attachment 3a)
0920-24FI
In-Depth Assessment – Evaluability Assessment Nomination Form – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Evaluability Assessment Nomination Form_WW (Attachment 3b)
0920-24FI
In-Depth Assessment – Evaluability Assessment Nomination Form – WISEWOMAN
Ex Assessment CCL Partner Interview Guide NCHP_ICHP (Attachment 4l)
0920-24FI
In-Depth Assessment – Exploratory Assessment Partner Interview Guide – Community Clinical Links – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment CCL Partner Interview Guide_WW (Attachment 4m)
0920-24FI
In-Depth Assessment – Exploratory Assessment Partner Interview Guide – Community Clinical Links – WISEWOMAN
Ex Assessment CCL Recipient Interview Guide NCHP_ICHP (Attachment 4j)
0920-24FI
In-Depth Assessment – Exploratory Assessment Recipient Interview Guide – Community Clinical Links – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment CCL Recipient Interview Guide_WW (Attachment 4k)
0920-24FI
In-Depth Assessment – Exploratory Assessment Recipient Interview Guide – Community Clinical Links – WISEWOMAN
Ex Assessment CQM Partner Interview Guide NCHP_ICHP (Attachment 4d)
0920-24FI
In-Depth Assessment – Exploratory Assessment Partner Interview Guide – Clinical Quality Measure – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment CQM Partner Interview Guide_WW (Attachment 4e)
0920-24FI
In-Depth Assessment – Exploratory Assessment Partner Interview Guide – Clinical Quality Measure – WISEWOMAN
Ex Assessment CQM Recipient Interview Guide NCHP_ICHP (Attachment 4b)
0920-24FI
In-Depth Assessment – Exploratory Assessment Recipient Interview Guide – Clinical Quality Measure – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment CQM Recipient Interview Guide_WW (Attachment 4c)
0920-24FI
In-Depth Assessment – Exploratory Assessment Recipient Interview Guide – Clinical Quality Measure – WISEWOMAN
Ex Assessment LC Interview Guide NCHP_ICHP (Attachment 4a)
0920-24FI
In-Depth Assessment – Exploratory Assessment Learning Collaborative Interview Guide – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment TBC Partner Interview Guide NCHP_ICHP (Attachment 4h)
0920-24FI
In-Depth Assessment – Exploratory Assessment Partner Interview Guide – Team-Based Care – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment TBC Partner Interview Guide_WW (Attachment 4i)
0920-24FI
In-Depth Assessment – Exploratory Assessment Partner Interview Guide – Team-Based Care – WISEWOMAN
Ex Assessment TBC Recipient Interview Guide NCHP_ICHP (Attachment 4f)
0920-24FI
In-Depth Assessment – Exploratory Assessment Recipient Interview Guide – Team-Based Care – The National Cardiovascular Health Program & The Innovative Cardiovascular Health Program
Ex Assessment TBC Recipient Interview Guide_WW (Attachment 4g)
0920-24FI
In-Depth Assessment – Exploratory Assessment Recipient Interview Guide – Team-Based Care – WISEWOMAN
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
316
0
0
316
0
0
Annual Time Burden (Hours)
484
0
0
484
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This is a new request for information collection.
Annual Cost to Federal Government:
$708,783
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Thelma Sims 4046394771
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
11/08/2024
An official website of the United States government
The .gov means it's official.
The site is secure.
